Predictive BioSciences Lands $21,750,000 Series B Financing
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2ed2f836-8b50-4d54-87cb-7def05b1cfec&Preview=1
Date 10/16/2008
Company Name Predictive BioSciences
Mailing Address 128 Spring Street, 400 Level, B Annex Lexington, MA 02421
Company Description Predictive Biosciences is a molecular diagnostics company headquartered in Lexington, MA. Launched in 2006 with a $10 million Series A financing, the company was jointly founded by leading healthcare investors, experienced entrepreneurs, and internationally-renowned scientists in the areas of tumor growth, tumor angiogenesis, and cancer markers. Predictive Biosciences possesses an extensive IP portfolio – including 18 issued US patents – and deep in-house expertise in proteomics, diagnostics, oncology, and tumor biomarkers.
Proceeds Purposes Predictive intends to use the proceeds from the Series B financing to complete current clinical validation studies and initiate multi-center clinical trials.